MASSAPEQUA, N.Y. and CLEVELAND, April 11 IBF Conferences,Inc., the leading national investment conference organizer, and BioEnterpriseCorporation, the Cleveland-based bioscience business formation, recruitment,and acceleration initiative, are proud to present the 2nd annual GlobalHealthcare Investing Conference. The conference brings together the leading-edge investors, institutions, providers and companies that invest inhealthcare technologies across the world, manage "global" start-ups, andoperate in multiple financial and regulatory markets.
The forum is geared specifically to US and international investors in andentrepreneurs of emerging bioscience companies. The event will be held April29 -- May 1, 2008 in Cleveland, Ohio, and is expected to once again draw over70+ investment firms and 300+ attendees.
This year, company presentations will be at the forefront of theconference. Each presenting company is ex-US or cross-border, and has receivedat least one round of professional funding. These companies span the lifescience industry, including medical devices, diagnostics, drug delivery, drugdiscovery, biotechnology and healthcare information technologies. This year'sselected presenting companies include the following:
This year's conference sponsors have raised the bar on helping securespeakers and presenting companies. 2008's sponsors include: Squire Sanders &Dempsey, LLP; Musculoskeletal Clinical Regulatory Advisers, LLC; UK Trade &Investment; and National City. To learn more about the event and to register,please visit www.globalhealthcareinvesting.com.
BioEnterprise is a business formation, recruitment, and accelerationeffort designed to support the growth of bioscience companies. Located inCleveland, BioEnterprise provides management counsel and support services tohealth care companies. BioEnterprise's partners are Case Western ReserveUniversity, the Cleveland Clinic, University Hospitals, and Summa HealthSystem. Additional technology partners include the NASA Glenn Research Center,Cleveland State University, NorTech and BioOhio.
The initiative comprises the collaborative activities of BioEnterprise andits partners' commercialization offices: the Case Office of TechnologyTransfer, Cleveland Clinic Innovations, University Hospitals Case MedicalCenter -- Center for Clinical Research, and Summa Enterprise Group. Thecombined efforts of these groups has created, recruited, and accelerated morethan 60 companies in four years.
About IBF Conferences
IBF -- International Business Forum presents financial and businessconferences on venture capital, corporate finance, mergers & acquisitions,corporate strategic investing, investment management, risk management, fundingtechnology innovation, commercialization of intellectual property andcorporate employee benefits. IBF conferences provide attendees withleading-edge information, and new business contacts to achieve businessobjectives.
Founded in 1989 by Alexandra Scott, International Business Forum organizesconferences to provide strategic information and key business contacts.Attendees include: venture capitalists, investment and commercial bankers,chief executive officers, chief financial officers, pension, endowment andfoundation investment officers, corporate investors, money managers, newbusiness development executives and corporate decision makers.Country Company Sector Shanghai, China GammaStar Medical Devices Group Ltd. Hoersholm, Denmark Santaris BioPharmaceutical Pharmaceutical California, USA Napo Pharmaceutical BioPharmaceutical Wurmlingen, Paradigm Spine, LLC Devices Germany Tokyo, Japan EyePlusPlus, Inc. Dev